Weaver C. Barksdale & Associates’s Patterson-UTI PTEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PTEN
PP
Weaver C. Barksdale & Associates's PTEN Position: Q4 2017 in Review
Weaver C. Barksdale & Associates increased its Patterson-UTI (PTEN) stake by 28% in Q4 2017, buying an estimated $2.2K and bringing the position to 485 shares worth $11K. The position accounts for 0.01% of the portfolio, ranked #267.
Weaver C. Barksdale & Associates first reported a position in PTEN in Q2 2013 and has held it in 19 quarters since. The position peaked at $15K in Q1 2015. 324 funds tracked by Wall St. Rank hold PTEN as of Q4 2017.
- Weaver C. Barksdale & Associates held 485 shares of Patterson-UTI worth $11K as of Q4 2017.
- Weaver C. Barksdale & Associates bought 106 Patterson-UTI shares in Q4 2017, an estimated $2.2K.
- Patterson-UTI made up 0.01% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #267 holding.
- Weaver C. Barksdale & Associates first reported a position in Patterson-UTI in Q2 2013 and has held it in 19 quarters since.
- Weaver C. Barksdale & Associates's Patterson-UTI position peaked at $15K in Q1 2015.
- 324 funds tracked by Wall St. Rank held Patterson-UTI as of Q4 2017.
Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.